论文部分内容阅读
目的观察腹水超滤浓缩回输治疗难治性腹水的临床疗效。方法选择难治性腹水病人66例,分为治疗组32例,对照组34例。两组常规护肝、利尿,同时治疗组应用WCFHY-500型伟力腹水超滤回输系统进行治疗。治疗前后观察体重、腹围、血清白蛋白及腹水吸收时间等变化。结果治疗组与对照组相比,在治疗后体重、腹围、血清白蛋白及腹水吸收时间方面均明显优于对照组(P<0.05)。治疗组未发现明显不良反应,无中止治疗者。结论腹水超滤浓缩回输是一种安全、简单、有效的方法。
Objective To observe the clinical efficacy of ascites ultrafiltration concentrated reinfusion in the treatment of refractory ascites. Methods 66 patients with refractory ascites were selected and divided into treatment group (32 cases) and control group (34 cases). Two groups of conventional liver protection, diuretic, while the treatment group WCFHY-500 Weili ascites ultrafiltration system for treatment. Body weight, abdominal circumference, serum albumin and ascites absorption time before and after treatment were observed. Results Compared with the control group, the body weight, abdominal circumference, serum albumin and ascites absorption time of the treatment group were significantly better than those of the control group (P <0.05). The treatment group found no obvious adverse reactions, no discontinuation of treatment. Conclusion Ascites ultrafiltration concentrated reinfusion is a safe, simple and effective method.